GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (OTCPK:ZLDAF) » Definitions » PB Ratio

ZLDAF (Zelira Therapeutics) PB Ratio : (As of Dec. 15, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Zelira Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-15), Zelira Therapeutics's share price is $0.3528. Zelira Therapeutics's Book Value per Share for the quarter that ended in Jun. 2024 was $-0.26. Hence, Zelira Therapeutics's PB Ratio of today is .

The historical rank and industry rank for Zelira Therapeutics's PB Ratio or its related term are showing as below:

During the past 13 years, Zelira Therapeutics's highest PB Ratio was 1.54. The lowest was 0.10. And the median was 0.35.

ZLDAF's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.48
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Zelira Therapeutics's average Book Value Per Share Growth Rate was -114.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Zelira Therapeutics was 72.20% per year. The lowest was -90.10% per year. And the median was -11.60% per year.

Back to Basics: PB Ratio


Zelira Therapeutics PB Ratio Historical Data

The historical data trend for Zelira Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelira Therapeutics PB Ratio Chart

Zelira Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.74 1.48 0.26 0.52 -

Zelira Therapeutics Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.31 0.52 - -

Competitive Comparison of Zelira Therapeutics's PB Ratio

For the Biotechnology subindustry, Zelira Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zelira Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zelira Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where Zelira Therapeutics's PB Ratio falls into.



Zelira Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Zelira Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=0.3528/-0.264
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Zelira Therapeutics  (OTCPK:ZLDAF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Zelira Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of Zelira Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zelira Therapeutics Business Description

Traded in Other Exchanges
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.